Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|May 27, 2026
Discovery of R-185 as a Potent and Orally Efficacious GPR52 Agonist with Potential for Treating Schizophrenia and Related Neuropsychiatric DisordersHaoran Li, Shuli Xia, Pengqi Zhang, et al.
Neurobiology of Disease|April 13, 2002
The estrogen receptor is not essential for all estrogen neuroprotection: new evidence from a new analogShuli Xia, Zu Yun Cai, Liu Lin Thio, et al.
Oncogene|February 27, 2018
Targeting UDP-α-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migrationOlutobi Oyinlade, Shuang Wei, Bachchu Lal, et al.
Cancer Science|October 15, 2020
Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancerChaoyan Wang, Menghan Weng, Shuli Xia, et al.
Stem Cells (Dayton, Ohio)|February 1, 2011
Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cellsMingyao Ying, Yingying Sang, Yunqing Li, et al.
Cancer Letters|June 10, 2018
Methylation-mediated miR-155-FAM133A axis contributes to the attenuated invasion and migration of IDH mutant gliomasGuo-Hao Huang, Lei Du, Ningning Li, et al.
Stem Cells Translational Medicine|November 3, 2018
Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic NeuronsYingchao Xue, Xiping Zhan, Shisheng Sun, et al.
Epigenetics|July 31, 2018
Analysis of KLF4 regulated genes in cancer cells reveals a role of DNA methylation in promoter- enhancer interactionsOlutobi Oyinlade, Shuang Wei, Kai Kammers, et al.
Cancer Research|April 29, 2021
EGFR Activates a TAZ-Driven Oncogenic Program in GlioblastomaMinling Gao, Yi Fu, Weiqiang Zhou, et al.
Marine Life Science & Technology|December 1, 2025
MR2938 relieves DSS-induced colitis in mice through inhibiting NF-κB signaling and improving epithelial barrierLing Lv, Mireguli Maimaitiming, Shuli Xia, et al.
Pageof 9